National University Corporation Asahikawa Medical University
发明人:
申请号：
EP17741503.1
公开号：
EP3400952A4
申请日:
2017.01.19
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
[Problem] To provide a highly safe and efficacious antitumor agent that is derived from probiotics. [Solution] The present invention relates to an antitumor agent comprising a compound represented by formula (1) or a complex thereof as an active ingredient. In formula (1): R 1 represents a hydrogen atom or a hydroxymethyl group； R 2 represents a hydrogen atom, a methyl group or a hydroxymethyl group； and R 3 , R 4 and R 5 each independently represent a methyl group, an N 5 -(trans-5-hydroxy-3-methylpent-2-enoyl) group, an N 5 -(cis-5-hydroxy-3-methylpent-2-enoyl) group or an N 5 -(trans-4-carboxy-3-methylpent-2-enoyl) group. According to the present invention, a highly safe and efficacious antitumor agent can be provided.
